Predictors of missed HIV screening opportunities among newly diagnosed individuals at an urban medical center in New York City, 2018-2022.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 15 03 2023
accepted: 08 08 2023
medline: 11 9 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: epublish

Résumé

To identify demographic and clinical factors predictive of having a missed opportunity (MO) for HIV screening. Retrospective cohort study. Electronic medical records were queried for individuals newly diagnosed with HIV in different sites within a large urban academic medical center in New York City between 2018 and 2022. The primary outcome was having one or more MO for HIV screening within the institution, defined as any encounter at which screening was not performed in the 365 days preceding the HIV diagnosis. Over one third of new diagnoses had at least one MO in the preceding year. Older individuals, cisgender women and those assigned female sex at birth, and heterosexual individuals were more likely to have at least one MO. An initial CD4 < 200 cells/ul was more likely among men who have sex with women specifically. Most MOs occurred in the emergency department and outpatient settings, with minimal HIV prevention discussions documented during each MO. These findings suggest that populations perceived to be at lower risk for HIV are more likely to have MOs and possibly late diagnoses, and that universal HIV screening must be implemented into the workflows of emergency department and outpatient settings to facilitate early diagnosis and reduce the incidence of HIV.

Identifiants

pubmed: 37676864
doi: 10.1371/journal.pone.0290414
pii: PONE-D-23-06075
pmc: PMC10484428
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0290414

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI069470
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069470
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI150378
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI114398
Pays : United States

Informations de copyright

Copyright: © 2023 Paer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

All authors have no conflicts of interest to disclose in relation to this study.

Références

Res Nurs Health. 2016 Apr;39(2):121-7
pubmed: 26829415
Med Decis Making. 2017 Feb;37(2):224-233
pubmed: 27646567
AIDS Patient Care STDS. 2022 Aug;36(8):313-320
pubmed: 35951445
Sex Transm Dis. 2021 Oct 1;48(10):e149-e152
pubmed: 34110753
PLoS One. 2017 Jul 21;12(7):e0180389
pubmed: 28732088
AIDS Patient Care STDS. 2009 Apr;23(4):245-50
pubmed: 19260771
AIDS. 2019 Jul 1;33(8):1335-1344
pubmed: 31157663
MMWR Morb Mortal Wkly Rep. 2018 Jun 29;67(25):714-717
pubmed: 29953427
J Med Internet Res. 2020 Oct 23;22(10):e23173
pubmed: 33095177
AIDS Patient Care STDS. 2014 Oct;28(10):530-6
pubmed: 25211596
MMWR Morb Mortal Wkly Rep. 2017 Dec 01;66(47):1300-1306
pubmed: 29190267
Cad Saude Publica. 2020 Jun 08;36(6):e00170118
pubmed: 32520126
PLoS One. 2021 Sep 20;16(9):e0257583
pubmed: 34543322
AIDS Patient Care STDS. 2016 Jun;30(6):247-53
pubmed: 27286295
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220936014
pubmed: 32588712
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
pubmed: 16988643
Int J STD AIDS. 2020 Oct;31(12):1169-1177
pubmed: 32936718
JMIR Public Health Surveill. 2022 Oct 26;8(10):e29890
pubmed: 36287600
Am J Emerg Med. 2021 Dec;50:102-105
pubmed: 34332216
Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S120-5.e1-3
pubmed: 21684390
J Womens Health (Larchmt). 2012 Feb;21(2):170-8
pubmed: 21950274
MMWR Morb Mortal Wkly Rep. 2019 Jun 28;68(25):561-567
pubmed: 31246940
MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):820-824
pubmed: 35737573
AIDS Res Treat. 2017;2017:5708620
pubmed: 28744377
Can Commun Dis Rep. 2015 Dec 03;41(12):302-321
pubmed: 29769925
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1725-1729
pubmed: 33211680
Qual Health Res. 2016 Feb;26(3):294-306
pubmed: 26631679
AIDS Patient Care STDS. 2018 Nov;32(11):432-437
pubmed: 30398951
Ann Emerg Med. 2004 Jul;44(1):31-42
pubmed: 15226706

Auteurs

Jeffrey Paer (J)

Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Judy Ratcliffe (J)

Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Michelle Chang (M)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Caroline Carnevale (C)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Daniela Quigee (D)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Peter Gordon (P)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Susan Olender (S)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Magdalena E Sobieszczyk (ME)

Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America.

Jason Zucker (J)

Division of Infectious Diseases, Department of Medicine and Pediatrics, Columbia University Medical Center, New York, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH